MCRP Micropolis AI Robotics
Price Chart
Executive Summary
Micropolis received a delisting notice from NYSE American for failing to file its FY 2025 annual report (Form 20-F) by the May 15, 2026 due date. The company has a six-month cure period until November 15, 2026; if unresolved, a potential additional six-month cure period through May 15, 2027 exists. The delay stems from ongoing audit-related matters. This is a material adverse event that introduces significant delisting risk and erodes investor trust, particularly given the company's small market cap (~$98M) and lack of an independent financial picture.
Actionable Insight
The immediate risk is delisting within 6-12 months if the 20-F is not filed. Absent financial clarity, the stock is likely to trade at a further discount to any fundamental value. Watch for the filing of the 20-F — if it reveals material weaknesses, going-concern language, or worse-than-expected numbers, downside could accelerate. Conversely, a clean filing within the cure period could partially restore credibility. Do not add new long positions without the 20-F in hand.
Key Facts
- Failed to timely file FY 2025 Form 20-F by May 15, 2026 deadline
- NYSE American issued delisting notice on May 18, 2026
- Initial cure period ends November 15, 2026; possible additional cure period through May 15, 2027
- Delay attributed to 'ongoing audit-related matters that require additional time to resolve'
- Prior late-filing notice (Form 12b-25) filed April 29, 2026
- No financial results or guidance provided in the filing
Financial Impact
No financial data provided; the 2025 annual report is past due, meaning current revenue, earnings, and cash position are unknown
Risk Factors
- Delisting if 20-F not filed by November 15, 2026; if not cured, trading could be suspended
- Unknown financial condition — delayed audit raises risk of adverse restatements or going-concern qualification
- Potential covenant defaults or financing restrictions triggered by late filing
- Historical model performance on this ticker shows significant post-filing underperformance (T+20 avg -38.41%)
- Low market cap (~$98M) amplifies volatility from any negative news
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-058751 |
| Document: ea029147001ex99-1.htm | 0001213900-26-058751 |
| Document: 0001213900-26-058751-index-headers.html | 0001213900-26-058751 |
| Document: 0001213900-26-058751-index.html | 0001213900-26-058751 |
| Document: 0001213900-26-058751.txt | 0001213900-26-058751 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
24d ago
|
6-K
| $2.69 $2.52 | ▲ +6.32% | ▲ +8.57% | $1.87 (+30.48%) |
|
May 19, 2026
24d ago
|
Press Release
| $2.69 $2.52 | ▲ +6.32% | ▲ +8.57% | $1.87 (+30.48%) |
|
Mar 3, 2026
14w ago
|
Press Release
| $4.14 $3.55 | ▼ −14.25% | ▼ −13.77% | $1.87 (−54.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access